福瑞达转让银座商管100%股权 剥离非核心资产聚焦主业

Core Viewpoint - The company Furuida plans to transfer 100% equity of its wholly-owned subsidiary Shandong Lushang Yinzou Commercial Management Co., Ltd. to its affiliate Lushang Furuida Health Investment Co., Ltd. for 88.4028 million yuan, aiming to optimize resource allocation and focus on its core businesses in pharmaceuticals and cosmetics [1][2]. Group 1: Transaction Details - The transaction constitutes a related party transaction as both parties are controlled by the same parent company, Shandong Provincial Commercial Group Co., Ltd. [1] - The transfer is part of Furuida's ongoing "slimming down" strategy, which includes divesting from non-core business lines [1]. Group 2: Financial Implications - The transaction is expected to improve Furuida's financial statements and cash flow, as the company reported a significant decline in operating cash flow by 86.26% year-on-year to 18.6774 million yuan for Q2 2025 [2]. - The subsidiary, Yinzou Commercial Management, has faced cumulative losses of approximately 1.5 million yuan for 2024 and the first half of 2025, heavily relying on internal real estate projects [1][2]. Group 3: Business Performance - Furuida's cosmetics segment is a key revenue driver, with a reported revenue of 1.79 billion yuan and a net profit of 108 million yuan for the first half of 2025 [2]. - The company's brands, including Yaili and Aier Bo, have shown strong growth, with Yaili achieving a revenue increase of 23.78% to 554 million yuan in the same period [2].